EdgeMarketInstruments › SKYE

SKYE — Skye Bioscience, Inc.

US Healthcare Pharma & biotech equity mkt cap 9.9M
2.24 -0.31% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.42 · high 4.75

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-04-11.

Performance

1 day-0.31%
1 week+346.66%
1 month+231.85%
3 months+213.42%
6 months+186.63%
Year to date+155.07%
1 year-36.00%

Technicals

RSI 1474.3
vs 50-day avg+185.74%
vs 200-day avg+154.94%
Volatility 1y602.0%
Max drawdown 1y-91.26%
Avg volume 30d676.0K
Daily bars held593
History from2024-04-11

Measured signals that fired on SKYE

datesignal measured base rate
2026-08-20Cluster sale: three or more insiders
insider
-0.36% over 21 days · t = -3.35 · n = 21,529
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-205AM Ventures VII, L.P.
10% owner
Open-market sale6.5K0.322.1K
2026-08-20Schwab Andrew J.
Director
Open-market sale6.5K0.322.1K
2026-08-205AM Partners II, LLC
10% owner
Open-market sale6.5K0.322.1K
2026-08-20PARMAR KUSH
10% owner
Open-market sale6.5K0.322.1K
2026-08-205AM Ventures II LP
10% owner
Open-market sale6.5K0.322.1K
2026-08-205AM Partners VII, LLC
10% owner
Open-market sale6.5K0.322.1K
2026-08-205AM CO-INVESTORS II LP
10% owner
Open-market sale6.5K0.322.1K
2026-08-20ROCKLAGE SCOTT M
10% owner
Open-market sale6.5K0.322.1K
2026-08-20DIEKMAN JOHN D
10% owner
Open-market sale6.5K0.322.1K
2026-08-20ROCKLAGE SCOTT M
10% owner
Open-market sale1.2K0.32371

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
5AM Venture Management, LLC6.0M9.7M
Versant Venture Management, LLC1.2M2.0M
BAKER BROS. ADVISORS LP968.1K1.6M
VANGUARD CAPITAL MANAGEMENT LLC470.1K764.5K
SPHERA FUNDS MANAGEMENT LTD.417.3K678.9K
BlackRock, Inc.175.9K286.1K
GEODE CAPITAL MANAGEMENT, LLC170.4K277.3K
MILLENNIUM MANAGEMENT LLC158.7K258.2K
PLATINUM INVESTMENT MANAGEMENT LTD143.3K233.1K
VANGUARD FIDUCIARY TRUST CO64.1K104.2K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
DEFA14A2026-08-14on EDGAR ↗
10-Q2026-08-142026-06-30on EDGAR ↗
8-K2026-08-142026-08-12on EDGAR ↗
42026-08-072026-08-07on EDGAR ↗
8-K2026-06-232026-06-18on EDGAR ↗
8-K2026-05-292026-05-26on EDGAR ↗
8-K2026-05-152026-05-13on EDGAR ↗
10-Q2026-05-112026-03-31on EDGAR ↗

Short selling

Avg short volume, 90d49.7% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about SKYE

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open SKYE in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →